EDITORIAL
Accepted on 07 Mar 2025
Editorial: Innovative Approaches to Catalyze Preclinical and Clinical Research on Amyotrophic Lateral Sclerosis (ALS) and Related Disorders
doi 10.3389/fnins.2025.1582539
- 349 views
- Frontiers in Neuroscience
- Neurodegeneration
- Research Topics
- Innovative Approaches to Catalyze Preclinical and Clinical Research on Amyotrophic Lateral Sclerosis (ALS) and Related Disorders
Innovative Approaches to Catalyze Preclinical and Clinical Research on Amyotrophic Lateral Sclerosis (ALS) and Related Disorders
3,203
Total downloads
11k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 05 Mar 2025
The systemic inflammation markers as potential predictors of disease progression and survival time in amyotrophic lateral sclerosis
doi 10.3389/fnins.2025.1552949
- 188 views
ORIGINAL RESEARCH
Accepted on 18 Feb 2025
Liquoral phosphorylatedPhosphorylated neurofilament heavy chain (pNfH) concentration in cerebrospinal fluid predicts overall disease aggressiveness (D50) in Amyotrophic Lateral Sclerosis
doi 10.3389/fnins.2025.1536818
REVIEW
Published on 18 Jul 2024
Potential contribution of spinal interneurons to the etiopathogenesis of amyotrophic lateral sclerosis
doi 10.3389/fnins.2024.1434404
- 1,031 views
- 1 citation
ORIGINAL RESEARCH
Published on 05 Mar 2024
Evidence based on Mendelian randomization and colocalization analysis strengthens causal relationships between structural changes in specific brain regions and risk of amyotrophic lateral sclerosis
doi 10.3389/fnins.2024.1333782
- 1,584 views
- 1 citation
ORIGINAL RESEARCH
Published on 08 Feb 2024
ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS
doi 10.3389/fnins.2024.1348157
- 5,258 views
- 1 citation
